SEC Filing Summary: INTELLIGENT BIO SOLUTIONS INC. (INBS)
Business Context and Reporting Period
This Form 8-K was filed on December 2, 2025, by Intelligent Bio Solutions Inc., a Delaware corporation trading on The Nasdaq Stock Market LLC under the symbol "INBS." The filing serves as a Regulation FD disclosure to furnish a presentation made available to investors on the same date regarding the Company's business and operations. The Company is classified as an emerging growth company.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a notice of a presentation rather than a financial statement containing quantitative data.
Material Changes
No material changes to financial performance or operations are detailed within the text of this filing. The document solely references the availability of an external presentation.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not explicitly detailed in this filing. The Company directs investors to a presentation accessible via the Investors section of its website (www.ibs.inc) for further information. The filing explicitly states that the information contained herein is furnished and not "filed" for purposes of the Exchange Act, nor is it incorporated by reference unless specifically identified.
Key Facts for Investor Verification
- Verify the content of the presentation referenced in Item 7.01 by visiting the Company's investor relations website.
- Confirm the Company's status as an emerging growth company and any associated accounting election implications.
- Note that the information in this 8-K is not incorporated by reference into other filings unless explicitly stated.
- Review the presentation for any forward-looking statements or operational updates not captured in this summary notice.